Recombinant Human SRXN1 Protein，His

SRXN1 (sulfiredoxin 1) is a pivotal antioxidant enzyme that plays a crucial role in cellular defense mechanisms against oxidative stress. It is primarily known for its ability to reduce hyperoxidized peroxiredoxins, thus maintaining redox homeostasis within the cell. The regulation of oxidative stress is vital for various physiological processes, including cell signaling, apoptosis, and inflammation. Dysregulation of SRXN1 expression has been implicated in several diseases, including cancer, neurodegenerative disorders, and cardiovascular diseases, highlighting its potential as a therapeutic target. Furthermore, SRXN1 is involved in various stress response pathways, working alongside other antioxidant proteins to protect cells from damage caused by reactive oxygen species (ROS). Understanding the structure and function of SRXN1, including the characterization of its recombinant protein, is essential for elucidating its biological role and therapeutic potential. Researchers are increasingly focused on the recombinant production of SRXN1 to explore its enzymatic activity, protein interactions, and post-translational modifications. This research aims to provide insights into the functional biology of SRXN1, enabling the development of targeted therapies that exploit its antioxidant properties to counteract oxidative damage in various diseases. By investigating the recombinant expression and activity of SRXN1, scientists hope to uncover novel strategies for enhancing cellular resilience against oxidative stress and promoting tissue repair and regeneration, thereby contributing to advances in disease management and therapeutic interventions.